290 related articles for article (PubMed ID: 21058918)
1. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
Saxena U
Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
[TBL] [Abstract][Full Text] [Related]
2. The amyloid cascade hypothesis has misled the pharmaceutical industry.
Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
[TBL] [Abstract][Full Text] [Related]
3. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
Shin J
Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
[No Abstract] [Full Text] [Related]
4. Alzheimer's disease: from pathology to therapeutic approaches.
Jakob-Roetne R; Jacobsen H
Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease 2012: the great amyloid gamble.
Marchesi VT
Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
[TBL] [Abstract][Full Text] [Related]
6. [Production and catabolism of amyloid peptides in Alzheimer's disease].
Checler F
Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
[TBL] [Abstract][Full Text] [Related]
7. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease.
Querfurth HW; LaFerla FM
N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
[No Abstract] [Full Text] [Related]
9. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
Fan LY; Chiu MJ
Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
Mullane K; Williams M
Biochem Pharmacol; 2013 Feb; 85(3):289-305. PubMed ID: 23178653
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapy for the treatment of Alzheimer's disease--the present state and the development in the future].
Yamaguchi N; Okada N; Sugiyama T
Nihon Rinsho; 2002 Jan; 60(1):107-11. PubMed ID: 11808319
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
[TBL] [Abstract][Full Text] [Related]
13. Preclinical success against Alzheimer's disease with an old drug.
LaFerla FM
N Engl J Med; 2012 Aug; 367(6):570-2. PubMed ID: 22873540
[No Abstract] [Full Text] [Related]
14. Targeting amyloid precursor protein secretases: Alzheimer's disease and beyond.
Ganjei JK
Drug News Perspect; 2010 Nov; 23(9):573-84. PubMed ID: 21152452
[TBL] [Abstract][Full Text] [Related]
15. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
16. γ-Secretase component presenilin is important for microglia β-amyloid clearance.
Farfara D; Trudler D; Segev-Amzaleg N; Galron R; Stein R; Frenkel D
Ann Neurol; 2011 Jan; 69(1):170-80. PubMed ID: 21280087
[TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase: a complex target for Alzheimer's disease.
Lundkvist J; Näslund J
Curr Opin Pharmacol; 2007 Feb; 7(1):112-8. PubMed ID: 17169612
[TBL] [Abstract][Full Text] [Related]
18. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
19. Progress in Alzheimer's disease drug discovery: an update.
Williams M
Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease.
Vardy ER; Catto AJ; Hooper NM
Trends Mol Med; 2005 Oct; 11(10):464-72. PubMed ID: 16153892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]